Recalled Medicines & supplements – Current GIS Alerts 2026
Found 685 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
PRESARTAN H
The risk may be caused by the presence of nitrosamine-group contaminants in the active substance contained in these medicinal products, which may affect human health and life. Potential effects: possible carcinogenic effects, chronic health risk, potential complications with long-term use.
KORZEŃ ARCYDZIĘGLA
Failure to meet quality requirements of the medicinal product was found due to the presence of disqualifying features, which makes a potential risk to patients’ health or life plausible. Potential effects: lack of efficacy, possible adverse effects or health complications.
GLICEROL
Out-of-specification results were found for aldehydes, sugars, impurity A and related substances during stability testing of batch 01916, which makes a potential threat to the quality and safety of the medicinal product plausible. Potential effects: lack of efficacy or unforeseen adverse reactions.
PULNEO O SMAKU COLI
An unfavourable benefit-risk balance was identified for the active substance fenspiride, which may represent a real and highly probable risk to patients’ health or life. Potential effects: serious adverse reactions, risk to health or life.
PULNEO
An unfavorable benefit-risk balance was found for the active substance fenspiride, indicating a potential risk to patients’ health or life that required immediate suspension of the medicinal product from the market. Potential effects: serious adverse reactions, risk to health or life, possible complications.
FOSIDAL O SMAKU MALINOWYM
Information was obtained about a threat to public health resulting from an unfavourable benefit-risk balance for the active substance fenspiride, which may cause a direct risk to patients’ health or life. Potential effects: serious adverse reactions, complications, threat to health or life.
PULNEO O SMAKU COLI
An unfavourable benefit-risk ratio for the active substance fenspiride, potentially posing a risk to patients’ health or life, with the probability of harm to a person considered significant. Potential effects: serious adverse reactions, complications, threat to health or life.
PULNEO
An unfavorable benefit–risk balance was identified for the active substance fenspiride, considered a potential threat to patients’ health or life, requiring immediate suspension of all product batches from the market. Potential effects: health complications, possible severe reactions, life‑threatening risk.
PULNEO
It was found that, based on new non-clinical studies, the benefit-risk ratio for the active substance fenspiride is not favorable, which may pose a real and highly probable threat to patients’ health or life. Potential effects: serious adverse reactions, complications, risk to health or life.
PULNEO
An unfavorable benefit-risk ratio for the active substance fenspiride, indicating a potential direct threat to patients’ health or life, requiring immediate suspension of marketing and re‑evaluation of treatment safety. Potential effects: serious adverse reactions, threat to health or life, possible treatment complications.
FOSIDAL O SMAKU POMARAŃCZOWYM
An unfavourable benefit-risk ratio was identified for the active substance fenspiride, associated with a potential, real and highly probable risk to patients’ health or life, requiring immediate action by supervisory authorities. Potential effects: serious adverse reactions, risk to health or life, possible cardiac complications.
FOSIDAL O SMAKU MALINOWYM
Unfavourable benefit–risk balance for the active substance fenspiride, which may pose a real and highly probable risk to patients’ health or life, even without damage having occurred so far. Potential effects: serious adverse reactions, complications, life‑threatening events.
FENSPOGAL
An unfavorable benefit–risk ratio was identified for the active substance fenspiride, which may pose a real and highly probable risk to patients’ health or life, requiring immediate suspension and prohibition of marketing the product. Potential effects: serious adverse reactions, risk to patient health or life.
EURESPAL
Unfavorable benefit-risk ratio of the active substance fenspiride; an urgent EU reassessment procedure was initiated. Potential effects: adverse reactions, health complications.
EURESPAL
Unfavourable benefit-risk ratio of the active substance fenspiride based on non-clinical studies; an urgent EU procedure was initiated due to a public health concern. Potential effects: serious adverse reactions, threat to health or life.
EURESPAL
An unfavorable benefit-risk ratio for the active substance fenspiride was identified based on non-clinical studies; an EU review procedure was initiated. Potential effects: deterioration of health, serious adverse reactions.
EURESPAL
Unfavorable benefit-risk ratio of the active substance fenspiride; an EU re-evaluation procedure was initiated. Potential effects: serious adverse reactions, risk to health or life.
EURESPAL
Unfavourable benefit–risk balance of the active substance fenspiride, which may pose a public health risk. Potential effects: deterioration of health, complications, life‑threatening risk.
EURESPAL
Unfavourable benefit-risk balance for the active substance fenspiride, posing a public health hazard. Potential effects: serious adverse reactions, threat to health or life.
EURESPAL
Unfavorable benefit-risk balance of the active substance fenspiride shown in non-clinical studies. Potential effects: threat to patients' health or life.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.